See also this year's filing and all EDGAR filings for this company.
PDF Report 0001607678_2019_Viking_Therapeutics_Inc.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001607678')"} |
Graph
Absolute values for 0001607678, Viking Therapeutics Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 302,133,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 179,000 |
| 4 | LiabilitiesCurrent | 4,550,000 |
| 5 | LiabilitiesNoncurrent | 12,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 7,121,000 |
| 9 | ResearchAndDevelopmentExpense | 19,040,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 4,098,000 |
| 13 | remainder_ComprehensiveNetIncome | -403,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 302,312,000 |
| 1 | Liabilities | 4,562,000 |
| 2 | Expenses | 26,161,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 297,750,000 |
| 5 | NetIncome | -22,063,000 |
| 6 | ComprehensiveNetIncome | -22,264,500 |
| 7 | BaseVar | 168,768,000 |
| 8 | EconomicCapitalRatio | 3.19 |
Edgar->Model Mapping
Feature Distribution
Change over Time
